Person:
Paredes Rodríguez, Víctor Manuel

Profile Picture
First Name
Víctor Manuel
Last Name
Paredes Rodríguez
URI
https://hdl.handle.net/20.500.14352/79816
Affiliation
Universidad Complutense de Madrid
Faculty / Institute
Odontología
Department
Especialidades Clínicas Odontológicas
Area
Estomatología
Identifiers
UCM identifierORCIDScopus Author IDDialnet ID

Filters

20171
Reset filters

Settings

Author: López-Pintor Muñoz, Rosa María × Subject: 616.314-089.843 ×

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Implant treatment in pharmacologically immunosuppressed liver transplant patients: A prospective‐controlled study
    (Clinical Oral Implants Research, 2017) Paredes Rodríguez, Víctor Manuel; López-Pintor Muñoz, Rosa María; Torres García Denche, Jesús; de Vicente, Juan Carlos; Sanz Alonso, Mariano; Hernández Vallejo, Gonzalo
    Abstract Objectives: The main objective of this prospective study was to evaluate the long-term outcome of implant therapy in liver transplant patients (LTP). The secondary goal was to assess several implant- and patient-dependent variables, such as peri-implantitis (PI), peri- implant mucositis (PIM), bone loss (BL), and immediate postoperative complications. Material and methods: Two groups, including 16 pharmacologically immunosup- pressed LTP and 16 matched controls, received 52 and 54 implants, respectively, be- tween 1999 and 2008. After evaluating the postoperative healing, a mean follow-up of more than 8 years was carried out, and radiographic, clinical, and periodontal pa- rameters were recorded to evaluate implant survival and implant- and patient- dependent outcomes. Results: The early postsurgical complications were similar in both groups. Implant sur- vival rate was 100% in the LTP group and 98.15% in the CG. PIM was diagnosed in 35.42% of the implants and 64.29% of the patients of LTP group (LTPG) and in 43.40% of the implants and 56.25% of the patients in the CG. PI was detected in 4.17% of the implants and 7.10% of the patients in the LTPG and in 9.43% of the implants and 18.80% of the patients in the CG. Conclusion: Pharmacologically immunosuppression in liver transplant patients was not a risk factor for implant failure, nor for the incidence of peri-implant diseases. Liver transplant is not a contraindication for dental implant treatment, although these pa- tients should be carefully monitored during follow-up care.